Annexon, Inc. Files 8-K Report
Ticker: ANNX · Form: 8-K · Filed: Mar 4, 2024 · CIK: 1528115
Sentiment: neutral
Topics: 8-K, regulatory-filing, financial-exhibits
TL;DR
Annexon filed a routine 8-K, mostly procedural stuff.
AI Summary
On March 1, 2024, Annexon, Inc. filed an 8-K report. The filing primarily serves as a notification of an event and includes financial statements and exhibits. No specific material events or financial updates were detailed in the provided excerpt.
Why It Matters
This filing indicates Annexon, Inc. is making a regulatory disclosure and submitting financial exhibits, which is a standard procedural step for public companies.
Risk Assessment
Risk Level: low — The filing is a standard procedural 8-K and does not appear to disclose any new material risks or events.
Key Players & Entities
- Annexon, Inc. (company) — Registrant
- 0001193125-24-058031 (filing_id) — Accession Number
- 20240304 (date) — Filing Date
- March 1, 2024 (date) — Earliest Event Reported
- 1400 Sierra Point Parkway, Bldg C, Suite 200 Brisbane, California 94005 (address) — Principal Executive Offices
- (650) 822-5500 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing by Annexon, Inc.?
The primary purpose of this 8-K filing is to serve as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, indicating a Regulation FD Disclosure and the filing of Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on March 1, 2024.
What is Annexon, Inc.'s principal executive office address?
Annexon, Inc.'s principal executive office is located at 1400 Sierra Point Parkway, Bldg C, Suite 200, Brisbane, California 94005.
What is the SIC code for Annexon, Inc.?
The Standard Industrial Classification (SIC) code for Annexon, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the filing date of this 8-K report?
The 8-K report was filed as of March 4, 2024.
Filing Stats: 580 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-03-04 17:25:36
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share ANNX The Nasdaq Stock Mar
Filing Documents
- d790221d8k.htm (8-K) — 24KB
- d790221dex991.htm (EX-99.1) — 56KB
- g790221ex99_1p10g1.jpg (GRAPHIC) — 324KB
- g790221ex99_1p11g1.jpg (GRAPHIC) — 253KB
- g790221ex99_1p12g1.jpg (GRAPHIC) — 323KB
- g790221ex99_1p13g1.jpg (GRAPHIC) — 291KB
- g790221ex99_1p14g1.jpg (GRAPHIC) — 378KB
- g790221ex99_1p15g1.jpg (GRAPHIC) — 324KB
- g790221ex99_1p16g1.jpg (GRAPHIC) — 213KB
- g790221ex99_1p17g1.jpg (GRAPHIC) — 321KB
- g790221ex99_1p18g1.jpg (GRAPHIC) — 388KB
- g790221ex99_1p19g1.jpg (GRAPHIC) — 316KB
- g790221ex99_1p1g1.jpg (GRAPHIC) — 369KB
- g790221ex99_1p20g1.jpg (GRAPHIC) — 402KB
- g790221ex99_1p21g1.jpg (GRAPHIC) — 369KB
- g790221ex99_1p22g1.jpg (GRAPHIC) — 303KB
- g790221ex99_1p23g1.jpg (GRAPHIC) — 378KB
- g790221ex99_1p24g1.jpg (GRAPHIC) — 237KB
- g790221ex99_1p25g1.jpg (GRAPHIC) — 259KB
- g790221ex99_1p26g1.jpg (GRAPHIC) — 275KB
- g790221ex99_1p27g1.jpg (GRAPHIC) — 281KB
- g790221ex99_1p28g1.jpg (GRAPHIC) — 253KB
- g790221ex99_1p29g1.jpg (GRAPHIC) — 174KB
- g790221ex99_1p2g1.jpg (GRAPHIC) — 314KB
- g790221ex99_1p30g1.jpg (GRAPHIC) — 238KB
- g790221ex99_1p31g1.jpg (GRAPHIC) — 268KB
- g790221ex99_1p32g1.jpg (GRAPHIC) — 256KB
- g790221ex99_1p33g1.jpg (GRAPHIC) — 246KB
- g790221ex99_1p34g1.jpg (GRAPHIC) — 346KB
- g790221ex99_1p35g1.jpg (GRAPHIC) — 353KB
- g790221ex99_1p36g1.jpg (GRAPHIC) — 242KB
- g790221ex99_1p37g1.jpg (GRAPHIC) — 334KB
- g790221ex99_1p38g1.jpg (GRAPHIC) — 353KB
- g790221ex99_1p39g1.jpg (GRAPHIC) — 282KB
- g790221ex99_1p3g1.jpg (GRAPHIC) — 607KB
- g790221ex99_1p40g1.jpg (GRAPHIC) — 279KB
- g790221ex99_1p41g1.jpg (GRAPHIC) — 304KB
- g790221ex99_1p42g1.jpg (GRAPHIC) — 321KB
- g790221ex99_1p43g1.jpg (GRAPHIC) — 374KB
- g790221ex99_1p44g1.jpg (GRAPHIC) — 308KB
- g790221ex99_1p45g1.jpg (GRAPHIC) — 212KB
- g790221ex99_1p46g1.jpg (GRAPHIC) — 272KB
- g790221ex99_1p47g1.jpg (GRAPHIC) — 284KB
- g790221ex99_1p48g1.jpg (GRAPHIC) — 284KB
- g790221ex99_1p49g1.jpg (GRAPHIC) — 179KB
- g790221ex99_1p4g1.jpg (GRAPHIC) — 239KB
- g790221ex99_1p50g1.jpg (GRAPHIC) — 340KB
- g790221ex99_1p51g1.jpg (GRAPHIC) — 263KB
- g790221ex99_1p52g1.jpg (GRAPHIC) — 336KB
- g790221ex99_1p53g1.jpg (GRAPHIC) — 366KB
- g790221ex99_1p54g1.jpg (GRAPHIC) — 356KB
- g790221ex99_1p55g1.jpg (GRAPHIC) — 222KB
- g790221ex99_1p56g1.jpg (GRAPHIC) — 191KB
- g790221ex99_1p5g1.jpg (GRAPHIC) — 358KB
- g790221ex99_1p6g1.jpg (GRAPHIC) — 256KB
- g790221ex99_1p7g1.jpg (GRAPHIC) — 251KB
- g790221ex99_1p8g1.jpg (GRAPHIC) — 207KB
- g790221ex99_1p9g1.jpg (GRAPHIC) — 331KB
- 0001193125-24-058031.txt ( ) — 23375KB
- annx-20240301.xsd (EX-101.SCH) — 3KB
- annx-20240301_lab.xml (EX-101.LAB) — 18KB
- annx-20240301_pre.xml (EX-101.PRE) — 11KB
- d790221d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Annexon, Inc. Presentation. 104 Cover Page Interactive Data File, formatted in inline XBRL.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: March 4, 2024 Annexon, Inc. By: /s/ Jennifer Lew Jennifer Lew Executive Vice President and Chief Financial Officer